Personalizing cancer care using genetic test results
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
This project looks at how genetic test results are used to guide treatment and prevention for adults with cancer in Georgia and California.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11299528 on NIH RePORTER |
What this research studies
If I have cancer, this project links my germline genetic test results with state cancer registry records from Georgia and California to see how those results influence care. Researchers will analyze data for adults diagnosed between 2013 and 2019 across multiple cancer types to compare real-world use of genetic information against clinical recommendations. The team will identify where genetic results changed treatment or prevention steps and where gaps or delays occurred. These findings will be used to shape better ways to deliver genetic-informed care to patients like me.
Who could benefit from this research
Good fit: Adults diagnosed with cancer in Georgia or California who had or are offered germline genetic testing, especially those with breast, ovarian, pancreatic, prostate, colorectal, or endometrial cancers.
Not a fit: People under age 21, those who never had germline genetic testing, or patients treated outside of Georgia and California are unlikely to be included or directly affected by this project.
Why it matters
Potential benefit: If successful, this work could help more patients receive appropriate genetic-based treatments and preventive care based on their test results.
How similar studies have performed: Prior linked-data work by this team showed genetic testing has increased but remains underused, and this project builds on those real-world findings rather than testing an untried method.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Kurian, Allison W. — Stanford University
- Study coordinator: Kurian, Allison W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.